Back Zander, M, Madsbad, S, Madsen, JL, Holst, JJ (9 March 2002) 'Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study', The Lancet , 359/9309, 824-30
Belli, M
While the potential cost of authorizing Medicare coverage of anti-obesity drugs has presented a barrier to enacting legislation to lift the prohibition, covering these drugs under Medicare for authorized uses has already catapulted these drugs to rank among the top-selling drugs covered by Part D, Medicares outpatient drug benefit program
The bottom line is that CRNAs must be hyper-vigilant in caring for patients prescribed GLP-1RAs
Visit HealthVerity Marketplace to access robust, real-world data on GLP-1 therapies and other high-impact drugs
It does not hit the basket evenly The headline is that these shoppers buy less